\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ and\\ vitals\\ normal\\.\\ \\ no\\ respiratory\\ complaints\\.\ \(0\)\
\-\ the\\ patient\\ denied\\ pulmonary\\ symptoms\\.\\ \\ the\\ patient\\ did\\ complain\\ of\\ persistent\\ headaches\\ in\\ the\\ days\\ following\\ the\\ embolization\\ procedure\\.\ \(0\)\
\-\ chest\\ radiograph\\ demonstrates\\ branching\\ opacity\\ in\\ a\\ bronchovascular\\ distribution\\ in\\ the\\ right\\ middle\\ lobe\\.\ \(0\)\
\-\ review\\ of\\ prior\\ imaging\\ demonstrates\\ presence\\ of\\ a\\ vein\\ of\\ galen\\ malformation\\ with\\ recent\\ embolization\\ treatment\\ with\\ onyx\\.\ \(0\)\
\-\ vein\\ of\\ galen\\ malformation\\,\\ onyx\\ embolization\\;\\ and\\,\\ \\ embolization\\ into\\ branches\\ of\\ the\\ pulmonary\\ arteries\\.\ \(0\)\
\-\ without\\ the\\ provided\\ history\\,\\ this\\ radiographic\\ finding\\ is\\ concerning\\ for\\ aspiration\\ of\\ contrast\\ or\\ other\\ radio\\-opaque\\ material\\.\ \(0\)\
\-\ 8\\ year\\ old\\ girl\\ status\\ post\\ vein\\ of\\ galen\\ aneurysm\\ onyx\\ embolization\\ treatment\\.\\ \\ a\\ chest\\ x\\-ray\\ was\\ ordered\\ to\\ confirm\\ endotracheal\\ tube\\ placement\\ following\\ an\\ uneventful\\ post\\-operative\\ course\\.\ \(0\)\
\-\ this\\ radiographic\\ finding\\ was\\ noted\\ immediately\\ following\\ embolization\\ of\\ the\\ patient\\'s\\ vein\\ of\\ galen\\ \\(vog\\)\\ malformation\\ using\\ the\\ liquid\\ embolic\\ agent\\,\\ onyx\\.\\ \\ onyx\\ is\\ a\\ relatively\\ new\\ material\\ composed\\ of\\ an\\ ethylene\\-vinyl\\ alcohol\\ copolymer\\,\\ dmso\\,\\ and\\ tantalum\\.\\ \\ tantalum\\ provides\\ the\\ radio\\-opaque\\ property\\ for\\ intraoperative\\ visualization\\ and\\ accounts\\ for\\ the\\ appearance\\ on\\ this\\ patients\\ chest\\ radiograph\\.\\ \\ \ \(0\)\
\-\ relatively\\ little\\ formal\\ analysis\\ of\\ the\\ efficacy\\ and\\ safety\\ of\\ the\\ use\\ of\\ onyx\\ in\\ the\\ treatment\\ intracerebral\\ avm\\'s\\ has\\ been\\ conducted\\.\\ \\ a\\ study\\ by\\ van\\ rooij\\ et\\ al\\,\\ revealed\\ an\\ average\\ of\\ 75\\%\\ reduction\\ in\\ the\\ volume\\ of\\ avm\\'s\\ with\\ a\\ complication\\ rate\\ of\\ 13\\.6\\%\\.\\ \\ jahan\\ et\\ al\\ reported\\ similar\\ numbers\\ of\\ 63\\%\\ and\\ 26\\%\\,\\ respectively\\.\\ \\ while\\ post\\-embolization\\ headaches\\ were\\ reported\\,\\ the\\ majority\\ of\\ collected\\ and\\ reported\\ problems\\ involved\\ hemorrhagic\\ complications\\.\\ \\ such\\ complications\\ are\\ postulated\\ to\\ be\\ secondary\\ to\\ physiologic\\ changes\\ in\\ the\\ regional\\ cerebral\\ blood\\ flow\\ surrounding\\ the\\ perinidal\\ tissues\\.\\ \\ proposed\\ solutions\\ to\\ such\\ complications\\ include\\ possible\\ staged\\ emobolization\\ procedures\\ such\\ to\\ produce\\ less\\-drastic\\ changes\\ in\\ flow\\ dynamics\\.\ \(0\)\
\-\ while\\ no\\ instances\\ of\\ symptomatic\\ pulmonary\\ embolism\\(pe\\)\\ were\\ reported\\ in\\ these\\ investigations\\,\\ symptomatic\\ pulmonary\\ embolism\\ is\\ a\\ serious\\ potential\\ consequence\\ of\\ accidental\\ peripheral\\ emobolization\\.\\ \\ as\\ in\\ this\\ patient\\â\\€\\™s\\ case\\,\\ the\\ risk\\ of\\ symptomatic\\ pe\\ is\\ likely\\ lower\\ if\\ only\\ small\\ volumes\\ of\\ the\\ embolic\\ agent\\ migrate\\ to\\ the\\ pulmonary\\ vasculature\\.\\ \\ this\\ is\\ a\\ risk\\ that\\ may\\ be\\ mitigated\\ with\\ careful\\ technique\\ and\\ intraoperative\\ observation\\.\ \(0\)\
\-\ references\ \(24\)\
\-\ van\\ rooij\\ et\\ al\\,\\ brain\\ avm\\ embolization\\ with\\ onyx\\.\\ american\\ journal\\ of\\ neuroradiology\\.\\ 28\\:172\\-177\\,\\ january\\ 2007\ \(0\)\
\-\ jahan\\ et\\ al\\,\\ embolization\\ of\\ arteriovenous\\ malformations\\ with\\ onyx\\:\\ clinicopathological\\ experience\\ in\\ 23\\ patients\\.\ \(0\)\
\-\ neurosurgery\\.\\ 48\\(5\\)\\:984\\-997\\,\\ may\\ 2001\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ onyx\\:\\ 0\\.46350498834820875\ \(0\)\
\-\ embolization\\:\\ 0\\.31589953109778884\ \(0\)\
\-\ of\\:\\ 0\\.1970375636712688\ \(0\)\
\-\ galen\\:\\ 0\\.19260209034376802\ \(0\)\
\-\ the\\:\\ 0\\.16875983210527817\ \(0\)\
\-\ tantalum\\:\\ 0\\.12881475177442903\ \(0\)\
\-\ jahan\\:\\ 0\\.12881475177442903\ \(0\)\
\-\ al\\:\\ 0\\.12800150209029276\ \(0\)\
\-\ et\\:\\ 0\\.1261967918325309\ \(0\)\
\-\ rooij\\:\\ 0\\.12308937224221986\ \(0\)\
\-\ emobolization\\:\\ 0\\.12308937224221986\ \(0\)\
\-\ pulmonary\\:\\ 0\\.12274521739423148\ \(0\)\
\-\ reported\\:\\ 0\\.11602993779875338\ \(0\)\
\-\ vein\\:\\ 0\\.11547253062363483\ \(0\)\
\-\ avm\\:\\ 0\\.10685668354705458\ \(0\)\
\-\ in\\:\\ 0\\.10018939153831688\ \(0\)\
\-\ van\\:\\ 0\\.09778879079484251\ \(0\)\
\-\ malformation\\:\\ 0\\.09318627069375711\ \(0\)\
\-\ intraoperative\\:\\ 0\\.09315014144209124\ \(0\)\
\-\ symptomatic\\:\\ 0\\.09290572639308521\ \(0\)\
\-\ complications\\:\\ 0\\.09253735562913744\ \(0\)\
\-\ agent\\:\\ 0\\.090112656180411\ \(0\)\
\-\ embolic\\:\\ 0\\.08687094491345992\ \(0\)\
\-\ such\\:\\ 0\\.07771945027209874\ \(0\)\
\-\ embolism\\:\\ 0\\.07302112253050093\ \(0\)\
\-\ following\\:\\ 0\\.07248225766931182\ \(0\)\
\-\ this\\:\\ 0\\.06919487643215934\ \(0\)\
\-\ material\\:\\ 0\\.0678495599947139\ \(0\)\
\-\ pe\\:\\ 0\\.06658956968613845\ \(0\)\
\-\ and\\:\\ 0\\.06657753067743465\ \(0\)\
\-\ post\\:\\ 0\\.06574359850873315\ \(0\)\
\-\ relatively\\:\\ 0\\.06559241267840571\ \(0\)\
\-\ property\\:\\ 0\\.06440737588721451\ \(0\)\
\-\ perinidal\\:\\ 0\\.06440737588721451\ \(0\)\
\-\ solutions\\:\\ 0\\.06440737588721451\ \(0\)\
\-\ mitigated\\:\\ 0\\.06440737588721451\ \(0\)\
\-\ chest\\:\\ 0\\.0637764516306772\ \(0\)\
\-\ vog\\:\\ 0\\.06154468612110993\ \(0\)\
\-\ copolymer\\:\\ 0\\.06154468612110993\ \(0\)\
\-\ dmso\\:\\ 0\\.06154468612110993\ \(0\)\
\-\ to\\:\\ 0\\.060410977629768416\ \(0\)\
\-\ headaches\\:\\ 0\\.06008261784312408\ \(0\)\
\-\ radiographic\\:\\ 0\\.05976046265269141\ \(0\)\
\-\ dynamics\\:\\ 0\\.05951357540842247\ \(0\)\
\-\ clinicopathological\\:\\ 0\\.05951357540842247\ \(0\)\
\-\ migrate\\:\\ 0\\.05793812354352609\ \(0\)\
\-\ treatment\\:\\ 0\\.05755436052438893\ \(0\)\
\-\ risk\\:\\ 0\\.05755347281274854\ \(0\)\
\-\ formal\\:\\ 0\\.05556254150430186\ \(0\)\
\-\ postulated\\:\\ 0\\.05556254150430186\ \(0\)\
\-\ is\\:\\ 0\\.055146955489204535\ \(0\)\
\-\ collected\\:\\ 0\\.05461977492963043\ \(0\)\
\-\ staged\\:\\ 0\\.0537881958762133\ \(0\)\
\-\ investigations\\:\\ 0\\.0537881958762133\ \(0\)\
\-\ flow\\:\\ 0\\.053651064998761606\ \(0\)\
\-\ numbers\\:\\ 0\\.05304432306473405\ \(0\)\
\-\ finding\\:\\ 0\\.05294573171893335\ \(0\)\
\-\ radiograph\\:\\ 0\\.05246265644395147\ \(0\)\
\-\ patient\\:\\ 0\\.052396833887901964\ \(0\)\
\-\ while\\:\\ 0\\.05205695604352217\ \(0\)\
\-\ bronchovascular\\:\\ 0\\.05175708516352585\ \(0\)\
\-\ safety\\:\\ 0\\.05175708516352585\ \(0\)\
\-\ consequence\\:\\ 0\\.05175708516352585\ \(0\)\
\-\ instances\\:\\ 0\\.05066874102550982\ \(0\)\
\-\ neuroradiology\\:\\ 0\\.05066874102550982\ \(0\)\
\-\ intracerebral\\:\\ 0\\.04972597445083839\ \(0\)\
\-\ efficacy\\:\\ 0\\.048894395397421256\ \(0\)\
\-\ changes\\:\\ 0\\.04868021678269381\ \(0\)\
\-\ liquid\\:\\ 0\\.048512666666842445\ \(0\)\
\-\ endotracheal\\:\\ 0\\.04780605125940523\ \(0\)\
\-\ january\\:\\ 0\\.04780605125940523\ \(0\)\
\-\ with\\:\\ 0\\.04731727045646662\ \(0\)\
\-\ accidental\\:\\ 0\\.04716376669960928\ \(0\)\
\-\ volumes\\:\\ 0\\.04716376669960928\ \(0\)\
\-\ conducted\\:\\ 0\\.04657507072104562\ \(0\)\
\-\ proposed\\:\\ 0\\.04657507072104562\ \(0\)\
\-\ an\\:\\ 0\\.04620227314486193\ \(0\)\
\-\ physiologic\\:\\ 0\\.04603170563131668\ \(0\)\
\-\ uneventful\\:\\ 0\\.045774940546717775\ \(0\)\
\-\ serious\\:\\ 0\\.045527186646088603\ \(0\)\
\-\ patients\\:\\ 0\\.04531299442196447\ \(0\)\
\-\ branching\\:\\ 0\\.04483217397204634\ \(0\)\
\-\ accounts\\:\\ 0\\.04483217397204634\ \(0\)\
\-\ regional\\:\\ 0\\.04483217397204634\ \(0\)\
\-\ complain\\:\\ 0\\.0446149180094744\ \(0\)\
\-\ careful\\:\\ 0\\.0446149180094744\ \(0\)\
\-\ provides\\:\\ 0\\.04419948868182139\ \(0\)\
\-\ composed\\:\\ 0\\.04380715099104679\ \(0\)\
\-\ average\\:\\ 0\\.04196948420594176\ \(0\)\
\-\ respectively\\:\\ 0\\.04168127024225358\ \(0\)\
\-\ technique\\:\\ 0\\.04154145851155434\ \(0\)\
\-\ were\\:\\ 0\\.04152047741271872\ \(0\)\
\-\ journal\\:\\ 0\\.04088114006792573\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.040756176421945824\ \(0\)\
\-\ malformations\\:\\ 0\\.04063338616729656\ \(0\)\
\-\ may\\:\\ 0\\.040534596924536904\ \(0\)\
\-\ demonstrates\\:\\ 0\\.04046674228476739\ \(0\)\
\-\ produce\\:\\ 0\\.040394032341045376\ \(0\)\
\-\ experience\\:\\ 0\\.0400495610145086\ \(0\)\
\-\ branches\\:\\ 0\\.039938373493254305\ \(0\)\
\-\ 2007\\:\\ 0\\.03982890987914612\ \(0\)\
\-\ little\\:\\ 0\\.03961494618134908\ \(0\)\
\-\ vasculature\\:\\ 0\\.03961494618134908\ \(0\)\
\-\ procedures\\:\\ 0\\.039510347798866884\ \(0\)\
\-\ 63\\:\\ 0\\.038913350512254745\ \(0\)\
\-\ concerning\\:\\ 0\\.038632773392666325\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.038632773392666325\ \(0\)\
\-\ visualization\\:\\ 0\\.038541671977937925\ \(0\)\
\-\ 2001\\:\\ 0\\.03801845030182115\ \(0\)\
\-\ observation\\:\\ 0\\.03777069640119198\ \(0\)\
\-\ confirm\\:\\ 0\\.03769000681799489\ \(0\)\
\-\ analysis\\:\\ 0\\.03745332783992189\ \(0\)\
\-\ alcohol\\:\\ 0\\.03722432630538155\ \(0\)\
\-\ immediately\\:\\ 0\\.03685842776457777\ \(0\)\
\-\ for\\:\\ 0\\.036620495103985115\ \(0\)\
\-\ complication\\:\\ 0\\.03657877688463408\ \(0\)\
\-\ majority\\:\\ 0\\.03657877688463408\ \(0\)\
\-\ denied\\:\\ 0\\.0363760760241904\ \(0\)\
\-\ potential\\:\\ 0\\.035987339589133686\ \(0\)\
\-\ vitals\\:\\ 0\\.035559313894746265\ \(0\)\
\-\ ordered\\:\\ 0\\.03538353066505942\ \(0\)\
\-\ volume\\:\\ 0\\.03538353066505942\ \(0\)\
\-\ 75\\:\\ 0\\.03532589555575669\ \(0\)\
\-\ aspiration\\:\\ 0\\.03521201789856515\ \(0\)\
\-\ reduction\\:\\ 0\\.03515576053571656\ \(0\)\
\-\ opacity\\:\\ 0\\.03504457301446227\ \(0\)\
\-\ problems\\:\\ 0\\.03493510940035408\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.03493510940035408\ \(0\)\
\-\ 48\\:\\ 0\\.03488100751353562\ \(0\)\
\-\ american\\:\\ 0\\.03436163653927697\ \(0\)\
\-\ distribution\\:\\ 0\\.03416413382360813\ \(0\)\
\-\ 23\\:\\ 0\\.03320920486577079\ \(0\)\
\-\ complaints\\:\\ 0\\.03316680076423818\ \(0\)\
\-\ review\\:\\ 0\\.03316680076423818\ \(0\)\
\-\ using\\:\\ 0\\.0331246498230291\ \(0\)\
\-\ provided\\:\\ 0\\.03304109545517846\ \(0\)\
\-\ 26\\:\\ 0\\.03271642852222152\ \(0\)\
\-\ be\\:\\ 0\\.032675348103483666\ \(0\)\
\-\ involved\\:\\ 0\\.03229307076961198\ \(0\)\
\-\ tube\\:\\ 0\\.032181883248357676\ \(0\)\
\-\ procedure\\:\\ 0\\.0321087192601334\ \(0\)\
\-\ references\\:\\ 0\\.0321087192601334\ \(0\)\
\-\ respiratory\\:\\ 0\\.032036305685013075\ \(0\)\
\-\ arteries\\:\\ 0\\.03196462728578573\ \(0\)\
\-\ tissues\\:\\ 0\\.031753857553970255\ \(0\)\
\-\ placement\\:\\ 0\\.031449050723227935\ \(0\)\
\-\ persistent\\:\\ 0\\.031030780815499655\ \(0\)\
\-\ use\\:\\ 0\\.030815418445987695\ \(0\)\
\-\ similar\\:\\ 0\\.030695240877480767\ \(0\)\
\-\ aneurysm\\:\\ 0\\.030665513415954224\ \(0\)\
\-\ rate\\:\\ 0\\.03051872514152343\ \(0\)\
\-\ course\\:\\ 0\\.02974875151776033\ \(0\)\
\-\ presence\\:\\ 0\\.02893746475167428\ \(0\)\
\-\ did\\:\\ 0\\.028891167787865667\ \(0\)\
\-\ middle\\:\\ 0\\.028799474788932987\ \(0\)\
\-\ peripheral\\:\\ 0\\.028799474788932987\ \(0\)\
\-\ girl\\:\\ 0\\.02825189335886861\ \(0\)\
\-\ status\\:\\ 0\\.028105885698257154\ \(0\)\
\-\ was\\:\\ 0\\.028071985634872093\ \(0\)\
\-\ cerebral\\:\\ 0\\.02790240586041081\ \(0\)\
\-\ new\\:\\ 0\\.02786240427078823\ \(0\)\
\-\ possible\\:\\ 0\\.027288082769565635\ \(0\)\
\-\ recent\\:\\ 0\\.027269720570185854\ \(0\)\
\-\ study\\:\\ 0\\.026860057075178214\ \(0\)\
\-\ surrounding\\:\\ 0\\.026860057075178214\ \(0\)\
\-\ revealed\\:\\ 0\\.026407643578711507\ \(0\)\
\-\ no\\:\\ 0\\.026193489174449323\ \(0\)\
\-\ days\\:\\ 0\\.0254953749420973\ \(0\)\
\-\ only\\:\\ 0\\.025161098941060497\ \(0\)\
\-\ brain\\:\\ 0\\.025106893210829716\ \(0\)\
\-\ appearance\\:\\ 0\\.024279815440116446\ \(0\)\
\-\ likely\\:\\ 0\\.024066927100128484\ \(0\)\
\-\ include\\:\\ 0\\.023962842733276216\ \(0\)\
\-\ secondary\\:\\ 0\\.023871594139308866\ \(0\)\
\-\ been\\:\\ 0\\.023464264229409844\ \(0\)\
\-\ if\\:\\ 0\\.02340037002246149\ \(0\)\
\-\ blood\\:\\ 0\\.02338977697969133\ \(0\)\
\-\ lobe\\:\\ 0\\.02327429057060303\ \(0\)\
\-\ these\\:\\ 0\\.022742891701837454\ \(0\)\
\-\ prior\\:\\ 0\\.022533542460074024\ \(0\)\
\-\ symptoms\\:\\ 0\\.022035816387441023\ \(0\)\
\-\ physical\\:\\ 0\\.02183765082410323\ \(0\)\
\-\ into\\:\\ 0\\.021409125376632476\ \(0\)\
\-\ noted\\:\\ 0\\.021353375699741054\ \(0\)\
\-\ without\\:\\ 0\\.02124317985791557\ \(0\)\
\-\ imaging\\:\\ 0\\.021165508429000737\ \(0\)\
\-\ other\\:\\ 0\\.020915091384104828\ \(0\)\
\-\ small\\:\\ 0\\.02077484111421591\ \(0\)\
\-\ lower\\:\\ 0\\.02058021208185825\ \(0\)\
\-\ exam\\:\\ 0\\.020274103534295873\ \(0\)\
\-\ case\\:\\ 0\\.020233371142383695\ \(0\)\
\-\ contrast\\:\\ 0\\.019568460815663918\ \(0\)\
\-\ has\\:\\ 0\\.01839612744412115\ \(0\)\
\-\ that\\:\\ 0\\.017477536514951802\ \(0\)\
\-\ by\\:\\ 0\\.017102804234185184\ \(0\)\
\-\ normal\\:\\ 0\\.01644372726439165\ \(0\)\
\-\ as\\:\\ 0\\.016179616274783013\ \(0\)\
\-\ history\\:\\ 0\\.015387114692965961\ \(0\)\
\-\ are\\:\\ 0\\.015282265766237991\ \(0\)\
\-\ or\\:\\ 0\\.014010712362680785\ \(0\)\
\-\ right\\:\\ 0\\.013352597340076412\ \(0\)\
\-\ year\\:\\ 0\\.012411746798258173\ \(0\)\
\-\ on\\:\\ 0\\.012163530359330085\ \(0\)\
\-\ old\\:\\ 0\\.01191957335910481\ \(0\)\
